ImmunologybioRxiv
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
A. M. Atalis, M. C. Keenum, B. Pandey…·K. Roy
This study shows that nanoparticle-delivered TLR4 and RIG-I agonists enhance immune responses to a SARS-CoV-2 subunit vaccine in mice, with route-specific effects on T and B cell responses.
DOI 10.1016/j.jconrel.2022.05.023